---
type: "NewsArticle"
title: "Alzheimer’s biomarkers marked a Parkinson’s subgroup with faster decline"
description: "In a prospective cohort, 42 of 449 biomarker-positive Parkinson’s participants met Alzheimer’s biomarker criteria and later showed greater cognitive and motor decline. The observational result is prognostic, not causal."
resource: "https://nootropikler.com/news/parkinsons-alzheimer-biomarker-cognitive-profiles"
tags: ["research", "brain", "cognition"]
timestamp: 2026-10-05T14:46:06Z
language: "en"
---

# Alzheimer’s biomarkers marked a Parkinson’s subgroup with faster decline

In a prospective cohort, 42 of 449 biomarker-positive Parkinson’s participants met Alzheimer’s biomarker criteria and later showed greater cognitive and motor decline. The observational result is prognostic, not causal.

Author: Nootropik News Editorial Team
Published: 2026-10-05T14:46:06Z
Update: 2026-10-05T14:46:06Z
News/source date: 2026-09-02
Production: AI-assisted sourced summary and translation; no independent medical expert review is claimed.

## Study design

Researchers analyzed de novo Parkinson’s disease participants in the PPMI cohort who tested positive on an alpha-synuclein seed amplification assay. They classified Alzheimer’s co-pathology using cerebrospinal-fluid amyloid-beta and phosphorylated-tau measures, then compared cognition and motor outcomes over follow-up.

## What the study found

Among 449 participants, 42 (9.3%) met the study’s Alzheimer’s biomarker definition. Their starting cognitive and motor scores were similar to the comparison group, but follow-up showed greater cognitive decline, more mild cognitive impairment at five years, and worse motor outcomes at eight years.

## Limits and interpretation

This is an observational subgroup analysis, and biomarker cutoffs and the selected PPMI population affect who is classified. The findings do not show that Alzheimer’s biomarkers cause faster decline or prove that routine screening changes outcomes.

## Sources

- [Cognitive and motor profiles in biologically defined Parkinson's and Alzheimer's disease](https://doi.org/10.1177/1877718X261477521) — 2026-09-02
